| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |